Video: Potential AIDS vaccine targets blood, mucosal tissue

November 27, 2013

December 1st is the annual World AIDS Day, a perfect opportunity to look at how medical research is progressing to fight the disease.

HIV is still plaguing humanity with 35 million infected people worldwide. Antiretroviral drugs do slow down the progression of the disease, but at a high cost and with long-term toxicity. More than ever, the need for a vaccine is urgent.

A current European research project seeks to block the entry of HIV into cells at mucosal sites and in the blood. Why target mucosal sites? Because 90% of HIV infections happen via the sexual route. Obtaining an immune response at this gateway could therefore mean efficiently blocking the virus and prevent it from ever entering the body.

A first clinical trial on humans has just finished to check for toxicity. In the next step, researchers will determine whether the blood and mucosal tissue of the volunteers produces the neutralizing antibodies after exposure to HIV in the lab.

Explore further: Texas Biomed files patent for a novel HIV vaccine strategy

Related Stories

Texas Biomed files patent for a novel HIV vaccine strategy

November 19, 2012
The Texas Biomedical Research Institute in San Antonio has applied for a patent for a genetically-engineered vaccine strategy to prevent HIV infection that targets the outer layers of body structures that are the first sites ...

Viral replication may not be primary cause of HIV-1 persistence in patients receiving cART

November 26, 2013
(Medical Xpress)—A team of researchers with members from Europe and the U.S. has found that viral replication may not be the main reason that the HIV virus is able to persist in the cells of infected patients for many years. ...

Newly discovered breast milk antibodies help neutralize HIV

May 22, 2012
Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...

Micronutrient supplements reduce risk of HIV disease progression and illness

November 26, 2013
Long-term (24-month) supplementation with multivitamins plus selenium for human immunodeficiency virus (HIV)-infected patients in Botswana in the early stages of disease who had not received antiretroviral therapy delayed ...

New target to fight HIV infection identified

October 1, 2013
A mutant of an immune cell protein called ADAP (adhesion and degranulation-promoting adaptor protein) is able to block infection by HIV-1 (human immunodeficiency virus 1), new University of Cambridge research reveals. The ...

Monoclonal antibodies show promise as effective HIV therapy

October 30, 2013
A research team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has demonstrated that a group of recently discovered antibodies may be a highly effective therapy for the treatment of HIV. Published on-line ...

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.